New data indicates that retatrutide, a dual-action medication, may represent a considerable advance in weight loss . This therapy combines the actions of a GLP-1 analog and a GIP agonist , seemingly offering a greater here outcome than current solutions. Patient research have shown promising outcomes, including substantial decreases in size and im